Pages that link to "Q40061963"
Jump to navigation
Jump to search
The following pages link to The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines (Q40061963):
Displaying 50 items.
- Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo (Q21245712) (← links)
- Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma (Q26799543) (← links)
- Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids (Q27329648) (← links)
- Natural killer cells in human cancer: from biological functions to clinical applications (Q27691427) (← links)
- Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma (Q33658562) (← links)
- Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model (Q34068174) (← links)
- Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells (Q34149109) (← links)
- Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape (Q34194706) (← links)
- Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells (Q34305570) (← links)
- A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies (Q34376968) (← links)
- A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab (Q34382125) (← links)
- Immune biomarkers of anti-EGFR monoclonal antibody therapy (Q34723594) (← links)
- Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy. (Q35054508) (← links)
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells (Q35153765) (← links)
- TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy (Q35510560) (← links)
- Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12. (Q35809223) (← links)
- A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer (Q35835138) (← links)
- Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation (Q35962555) (← links)
- Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines (Q36204962) (← links)
- Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function (Q36548443) (← links)
- Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines (Q36624335) (← links)
- Correlation between NK function and response to trastuzumab in metastatic breast cancer patients (Q36702442) (← links)
- NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines (Q36759187) (← links)
- Toll-like receptor 2 ligands regulate monocyte Fcγ receptor expression and function (Q36796964) (← links)
- Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients (Q36806268) (← links)
- Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells (Q36916476) (← links)
- Novel immunogenic HLA-A*0201-restricted epidermal growth factor receptor-specific T-cell epitope in head and neck cancer patients (Q36962838) (← links)
- Folate-conjugated immunoglobulin targets melanoma tumor cells for NK cell effector functions (Q37053016) (← links)
- Cetuximab intensifies the ADCC activity of adoptive NK cells in a nude mouse colorectal cancer xenograft model (Q37204600) (← links)
- Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies (Q37393024) (← links)
- Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. (Q37593624) (← links)
- Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors (Q37628728) (← links)
- Current and Potential Uses of Immunocytokines as Cancer Immunotherapy (Q37637949) (← links)
- Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer (Q37707275) (← links)
- Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer. (Q37778700) (← links)
- Head and Neck Squamous Cell Carcinoma: New Translational Therapies (Q37812071) (← links)
- Immunomodulating antibodies and drugs for the treatment of hematological malignancies (Q37832694) (← links)
- The molecular biology of colorectal carcinoma and its implications: A review (Q37889461) (← links)
- Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity (Q37895956) (← links)
- Combination strategies to enhance antitumor ADCC. (Q38014085) (← links)
- Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy (Q38142315) (← links)
- Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer (Q38214511) (← links)
- Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer (Q38233046) (← links)
- Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer (Q38240998) (← links)
- IL-21: a pleiotropic cytokine with potential applications in oncology (Q38471387) (← links)
- The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas (Q38831202) (← links)
- Interleukin 21 - its potential role in the therapy of B-cell lymphomas. (Q38894228) (← links)
- The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma (Q39062237) (← links)
- Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ. (Q39121775) (← links)
- Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma (Q39290976) (← links)